A culture recovers only organisms that reach the laboratory viable. Recovery requires a specimen taken from the true site of infection, at a time when the organism is present, and in a volume the method can detect. Transport conditions must keep the pathogen viable and limit overgrowth of contaminating flora. Collection and transport therefore determine which organisms and contaminants reach every later step, from the Gram stain to the final susceptibility report.1
Acid-fast and modified acid-fast staining are covered in mycobacteriology, and potassium hydroxide (KOH), calcofluor-white, trichrome, and Giemsa preparations are covered in mycology and parasitology.
Collection
Collect bacterial specimens before antimicrobial therapy begins, because even a single dose can suppress growth in culture. Viral specimens give the highest yield during the acute phase of illness, when shedding peaks. Specimen volume is as important as timing. Most methods have a minimum volume below which sensitivity falls sharply. Request recollection of an underfilled specimen, or ask the ordering clinician to prioritize the requested tests when the volume is insufficient for all of them.1
Collect from the actual site of infection with as little contact with adjacent tissue and secretions as the site allows. Every specimen except stool goes into a sterile container. The label must include the patient's name or unique identifier and the specimen source.2 Laboratory procedure also requires the date and time of collection on the label, because every transport limit is measured from the collection time.1,3 Whether an isolate is a pathogen or a contaminant depends on the body site the specimen came from and that site's resident flora. Urine container, labeling, and preservation practice is covered in Specimen Handling and Acceptability.
Swabs. A swab traps much of the collected material in its own fibers, so it delivers less specimen than an aspirate or a tissue sample. Use swabs for sites that cannot be sampled by aspiration or biopsy, such as the throat, the nasopharynx, or the cervix. Swabs are poor specimens for anaerobic, mycobacterial, and fungal culture. Send aspirated fluid or tissue for these cultures whenever the site permits.1
Swab tip and shaft materials affect recovery. Some materials are toxic to the target organism, and others inhibit the amplification enzymes of a molecular assay:
Scroll sideways to see all columns
| Swab component | Appropriate use | Avoid | Reason |
|---|---|---|---|
| Dacron, rayon, or nylon tip on a plastic shaft | Default for bacterial culture, gonococcal culture, and nucleic acid amplification tests (NAAT) | Broadly compatible with culture and molecular methods4,3 | |
| Calcium alginate tip | Acceptable for gonococcal culture4 | NAAT and polymerase chain reaction (PCR); viral culture | Some manufacturing lots have killed gonococci, an effect traced to the adhesive used to attach the fibers and reduced by charcoal-containing transport medium.5 The fibers inhibit PCR after brief contact and can inactivate herpes simplex virus6 |
| Cotton tip | General bacterial collection | Gonococcal culture | The Centers for Disease Control and Prevention (CDC) advises against cotton for gonococcal culture because it may inhibit the organism4 |
| Wooden shaft | General bacterial collection | Chlamydia trachomatis culture | Wood components can inhibit isolation of chlamydiae4 |
| Aluminum shaft | Culture-only collection | Molecular assays | Metal shaft components inhibit PCR after prolonged specimen contact, on the order of 48 hours of storage6 |
The standard choice for gonococcal culture and for any NAAT is a plastic-shafted Dacron, rayon, or nylon swab.4,3 Validate any other combination of fiber, shaft, and transport against the specific assay before use. Molecular assays cleared by the Food and Drug Administration (FDA) list their acceptable collection devices in the manufacturer's instructions, so use a device from that list.4
Transport
Transport and acceptability limits depend on the requested test and collection system, so follow your laboratory's validated, test-specific instructions. The delayed-transport times below are examples. Your laboratory's instructions set its own rejection limits.
Transport temperature depends on the organisms expected at the collection site. Sterile-site fluids, blood, and gonococcal specimens may contain refrigeration-sensitive pathogens, so keep them at room temperature when delivery is delayed. Urine, respiratory secretions, and stool contain heavy resident flora that overgrows a pathogen at room temperature within hours, so refrigerate these specimens when delivery is delayed.1,3
Scroll sideways to see all columns
| Keep at room temperature | Refrigerate when delayed |
|---|---|
| Cerebrospinal fluid and other sterile body fluids | Urine without preservative, after about 30 minutes |
| Blood and inoculated blood culture bottles | Sputum and other respiratory specimens, after about 2 hours |
| Specimens for N. gonorrhoeae culture | Stool without preservative, after about 1 hour |
| Stool in Cary-Blair or an equivalent enteric transport medium | Specimens for chlamydial or viral culture, including viral transport medium |
Never refrigerate cerebrospinal fluid (CSF) for culture. Store and transport specimens collected into an FDA-cleared molecular collection kit as the kit instructions specify. These instructions commonly permit room temperature. The refrigeration rule above applies to culture specimens and viral transport medium.4,3
Scroll sideways to see all columns
| Transport system | Examples | Typical use |
|---|---|---|
| Sterile containers | Screw-cap cups, stoppered tubes | Fluid and tissue specimens |
| Swabs | Flocked swabs in liquid transport medium; fiber-wound swabs in gel transport | Mucosal surface sampling. The liquid medium of a flocked-swab system releases the collected material for culture or molecular testing |
| Extraction devices | Swab Extraction Tube System (SETS) | Centrifugation drives swab-trapped fluid into an outer tube for molecular testing |
| Molecular stabilizing media | Nucleic-acid-preserving buffers supplied with molecular kits | Specimens awaiting extraction |
| Anaerobic transport | Gassed-out vials and tubes with reducing agents | Aspirates and tissue for anaerobic culture |
| Viral transport medium (VTM) | Antibiotic-supplemented isotonic broth | Viral culture and molecular testing. Unsuitable for routine bacterial culture |
Molecular specimens. Nucleic acid testing does not require a viable organism, because lysed and dead cells still contain amplifiable target. It does require intact nucleic acid. DNA, and especially RNA, degrades quickly once cells lyse, so send molecular specimens promptly in a stabilizing medium. RNA targets require RNase-free handling of tubes, reagents, and work surfaces. Amplification can detect a single template molecule, so contamination control is as important as preventing degradation. Carryover from another specimen or a prior amplification can produce a false-positive result. When you suspect a control failure or a contamination event, stop releasing results and investigate before any result is reported.1,2
This high sensitivity also affects interpretation. A positive molecular result can represent colonization, resolved infection, or an organism burden below clinical significance. Interpret the detection with the quantity and the clinical context. A primer set designed against one strain can miss a divergent variant of the same species. Collection timing must also match the stage of infection. In typhoid fever, blood culture is the preferred early specimen, although a single set detects only about half of cases. Stool culture is usually still negative during the first week of illness.7
The control-failure explanation gives the criteria for releasing patient results after a control failure.
Extraction of microbial nucleic acid follows the same principles as human-cell extraction, with four organism-specific complications:1
- Lysis resistance varies with cell-wall architecture. Mycobacteria have a lipid-rich, mycolic-acid-containing envelope, and fungal walls are built from structural polysaccharides such as glucans and chitin. Both resist lysis and need mechanical or chemical disruption, with an intensity matched to the organism and the validated assay. Gram-positive walls resist lysis more than gram-negative walls, and Mycoplasma species, which have no cell wall, lyse so easily that target can be lost to rough handling before extraction begins.
- Concentration must match the reaction volume. Milliliter-scale fluids are centrifuged down to the microliter volumes used in extraction and amplification.
- Amplification inhibitors must be removed. Hemoglobin and its breakdown products inhibit the polymerase in whole blood, and acidic polysaccharides inhibit it in sputum. Inhibitors in urine include urea, crystals, and hemoglobin.
- RNA work adds RNase control at every step.
The preparation depends on the specimen type. Whole blood is processed to concentrate leukocytes, which harbor intracellular organisms and cell-associated viruses. Density-gradient separation is the classical method, and automated extraction platforms that remove hemoglobin now perform most routine extractions. Serum and plasma are the preferred sources for cell-free viral nucleic acid. Sputum needs inhibitor removal before extraction, and urine and CSF are centrifuged to pellet organisms.1
Shipping to a reference laboratory. Referred specimens and cultures ship under the dangerous-goods rules as triple packages: a sealed primary receptacle; a leakproof secondary container with absorbent material sufficient to soak up the entire contents, with multiple primary tubes individually wrapped or separated; and a rigid outer shipping container. For Category B infectious substances (UN 3373) shipped by air, each primary receptacle is limited to 1 L and the outer package to 4 L. Category A packages have stricter limits, 50 mL or 50 g per package on a passenger aircraft and 4 L or 4 kg on a cargo aircraft, and add requirements such as an itemized contents list between the secondary and outer layers and taped, positively sealed closures.8
Receipt, prioritization, and rejection
Triage specimens by urgency, stability, and whether another specimen can be collected. When a compromised specimen cannot be replaced, contact the ordering service promptly and escalate through your laboratory's documented exception procedure. Resolve identity discrepancies before assigning a patient result. A clinician's request to proceed does not establish specimen identity. Document the acceptance decision and any limitation that must accompany the report. Recollect replaceable specimens that fail the applicable acceptance criteria.2
Each laboratory director establishes the site's written acceptability and rejection criteria under the Clinical Laboratory Improvement Amendments (CLIA).2 The following rejections are standard for bacterial culture across clinical microbiology laboratories. Two entries are culture-specific and are marked as such, because the same specimen may be acceptable for a validated molecular assay or as part of a scheduled serial collection:1,3
Scroll sideways to see all columns
| Reject | Reason |
|---|---|
| Unlabeled specimen, or label that does not match the requisition | Patient identity cannot be verified |
| Any specimen received in formalin (culture only) | Formalin kills organisms, so culture is impossible. Fixed tissue can still be acceptable for a validated molecular assay |
| 24-hour sputum collection | Overgrown by contaminants during pooling |
| Leaking container | Contamination of the specimen and exposure hazard for staff |
| Specimen received past its transport time limit or outside its temperature limit | Pathogen loss and flora overgrowth make growth uninterpretable |
| Specimen contaminated with barium, dye, or oily chemicals | The contaminants interfere with recovery and reading |
| Foley catheter tip | Colonized by urethral flora; growth does not represent infection |
| Duplicate specimen within 24 hours, except blood cultures and test-specific serial collections | Adds no information for the reagents and labor spent. A scheduled series, such as three sputum specimens collected 8 to 24 hours apart for acid-fast culture, is not a duplicate |
| Intravascular catheter tip without a paired blood culture | Tip growth cannot be interpreted without a blood result |
Additional specimen types are rejected specifically for anaerobic culture because they are routinely contaminated with anaerobic resident flora that culture cannot distinguish from an anaerobic pathogen: gastric washings; urine other than a suprapubic aspirate; stool, except when anaerobic culture is specifically requested for outbreak typing or a suspected foodborne pathogen, since routine Clostridioides difficile testing uses toxin and nucleic acid assays; oropharyngeal specimens other than deep tissue collected at surgery; sputum; swabs of ileostomy or colostomy sites; and superficial skin specimens.1
Worker protection
Treat every specimen as infectious. Organisms are inactivated at different points in collection, transport, and processing, and a processed specimen may still contain viable pathogens. Culture is the most exposure-prone step of a traditional workup, so molecular methods that test inactivated specimens directly are inherently safer.1 Standard Precautions apply to blood; to all body fluids, secretions, and excretions except sweat, regardless of visible blood; to nonintact skin; and to mucous membranes. CDC created Standard Precautions in 1996 by unifying Universal Precautions, which addressed bloodborne pathogens, with Body Substance Isolation, which addressed organisms on moist body surfaces. The current statement is in the 2007 isolation-precautions guideline.9 The bloodborne pathogens standard of the Occupational Safety and Health Administration (OSHA) remains the enforceable federal regulation behind this practice and still uses the term universal precautions.10 Under CLIA the laboratory director may delegate safety duties to other staff and remains accountable for a safe laboratory environment.2 Handle a specimen suspected of containing a select agent, such as variola virus, only within the containment the agent requires, and refer it to the public health laboratory network. Maximum-containment work is restricted to biosafety level 4 facilities.11
Biological safety cabinet. The Class II Type A2 cabinet is the routine containment device in clinical microbiology. It protects the worker, the specimen, and the room. An inward air barrier at the sash, with a minimum face velocity of 100 linear feet per minute, sweeps room air into the cabinet and keeps aerosols out of the worker's breathing zone. Downflow air passed through a high-efficiency particulate air (HEPA) filter flows over the work surface and protects the specimen from room contamination. Exhaust air passes through a second HEPA filter before it returns to the room or leaves through a canopy connection. Recirculation to the room is acceptable only when no volatile toxic chemicals are used in the cabinet, because HEPA filters trap particulates and let vapors through. Use a chemical fume hood for work with volatile or flammable chemicals.11
Containment depends on work practices as much as on the cabinet. Move your arms in and out slowly so the air curtain stays intact. Keep the front and rear grilles clear of equipment, paper, and elbows. Work at least 4 inches inside the sash. Decontaminate the work surface before and after use and immediately after any spill, and run the cabinet for several minutes before and after work to purge airborne contaminants. Under the laboratory's accreditation requirements, each cabinet is certified to the NSF/ANSI 49 standard at installation, at least annually, after relocation, and after filter replacement or internal repair.11
Open and subculture any specimen or culture that may contain Mycobacterium tuberculosis, a mold, or a select agent inside a certified cabinet. Perform every aerosol-generating manipulation, including grinding tissue, vortexing, sonicating, and opening lyophilized cultures, inside the cabinet regardless of the suspected organism. The manipulation creates the aerosol hazard.11
Personal protective equipment and biosafety levels. Wear gloves, a fluid-resistant laboratory coat or gown, and face or eye protection for any procedure that could splash or aerosolize material. When an aerosol-generating procedure on a specimen likely to contain M. tuberculosis must be performed outside a biological safety cabinet, a fit-tested N95 respirator is the minimum respiratory protection. A powered air-purifying respirator (PAPR) gives a higher level of protection and is selected by risk assessment. Any respirator use falls under the OSHA respiratory protection program, which includes medical evaluation and training. Fit testing applies to tight-fitting respirators, including the N95 and tight-fitting PAPR facepieces. A loose-fitting PAPR hood or helmet does not require fit testing.10,12 A respirator is the last control in the hierarchy and protects the worker only from aerosol that has escaped cabinet containment. Routine bacteriology is performed at biosafety level 2 (BSL-2). For M. tuberculosis, clinical specimens are processed at BSL-2 with every manipulation inside a biological safety cabinet, and propagation or manipulation of cultures requires BSL-3, which adds directional inward airflow and controlled laboratory access.11
Direct examination
The direct smear is the first examination of the specimen. It gives the clinician same-day information. It gives the laboratory a check on specimen quality and a guide to how much workup a recovered organism needs. An organism seen in abundance with many white blood cells warrants more identification work than the same organism seen sparsely with no inflammatory response. Recovery of the same organism from repeated specimens from one patient supports the significance of the isolate.1
Gram stain. Spread an aliquot of the most purulent or bloody portion of the specimen to give a thick and a thin area, then air-dry and fix it. Methanol fixation is preferred because it preserves cell morphology and avoids the background distortion of heat. Gentle heat remains an acceptable alternative. Cytocentrifuge sterile fluids such as CSF first. Cytocentrifugation increases the yield of visible organisms by up to about 100-fold and can make a low organism burden detectable.1,13 The smear is stained with crystal violet, Gram's iodine, a decolorizer, and safranin. Gram-positive walls retain the purple crystal violet-iodine complex during decolorization. Gram-negative walls decolorize and take the safranin counterstain, pink to red.
Start at low power to find large structures such as nematode larvae, Curschmann spirals, sulfur granules, microcolonies, and fungal forms, then move to oil immersion at 1,000× to characterize bacteria. Roughly 105 organisms per milliliter must be present for about one organism to appear per oil-immersion field, so a negative smear does not rule out a low-burden infection.1
Describe size, shape, arrangement, and Gram reaction as specifically as the smear allows. A result of "gram-positive cocci in pairs, morphology consistent with S. pneumoniae" guides therapy far better than "gram-positive cocci." Quantify white blood cells and squamous epithelial cells, because they indicate inflammation and, in respiratory specimens, oropharyngeal contamination. The numeric adequacy thresholds for sputum are applied with the respiratory workup. Note intracellular organisms. Compare the smear with the culture. Organisms seen on the smear that fail to grow suggest an organism that needs special media, or a false-positive smear from contaminated reagents or misreading. For example, gram-negative coccobacilli that do not grow on blood agar suggest Haemophilus, and a chocolate plate on the next specimen can recover it. When one organism grows heavily in culture and was not seen on the smear, consider an organism burden below the smear's detection limit, sampling of a different part of the specimen, the smear's limited sensitivity, or contamination of the culture. Investigate each possibility.1
Acridine orange. Acridine orange is a fluorochrome that intercalates into nucleic acid. In a smear buffered to about pH 4, bacterial and fungal nucleic acid fluoresces bright orange under blue or ultraviolet excitation. Human cell material fluoresces green. This color difference depends on the acidic staining conditions and is lost near neutral pH. Prepare and fix the smear as for a Gram stain, flood it with working solution, rinse, and read it promptly on a fluorescence microscope fitted with the correct excitation and barrier filters, because the fluorescence fades.1
The stain detects roughly 104 organisms per milliliter, below the Gram stain's threshold. Its three classic uses are re-examining a Gram-stained smear with no organisms seen from a sterile site when infection is still suspected, screening blood culture broth for early growth before turbidity appears, and screening cell cultures for Mycoplasma, which lacks a cell wall and stains poorly by Gram. Its limitations follow from its chemistry. It stains all organisms alike and gives no Gram reaction. It stains nucleic acid in live and dead organisms, and background debris can fluoresce. Follow a positive result with a Gram stain or culture before it can guide therapy. It also requires a fluorescence microscope.1
Media selection and inoculation
Media are chosen to support the pathogens expected at a site and to select them from the resident flora:1
Scroll sideways to see all columns
| Medium type | Example | Mechanism |
|---|---|---|
| Enriched, nonselective | Sheep blood agar | Supports most routine organisms. The hemolysis pattern aids identification |
| Enriched for fastidious organisms | Chocolate agar | Heat-lysed blood releases hemin (X factor) and nicotinamide adenine dinucleotide (NAD, V factor) for Haemophilus and other fastidious organisms |
| Selective for gram-positives | Colistin-nalidixic acid (CNA) agar, phenylethyl alcohol (PEA) agar | Added antibiotics or chemicals suppress gram-negative bacilli |
| Selective and differential for gram-negatives | MacConkey agar | Bile salts and crystal violet suppress gram-positives; lactose fermenters turn the neutral red indicator pink |
| Backup broth | Thioglycolate and similar supportive broths | Recovers small numbers of organisms, including many anaerobes, that plates alone might miss |
| Reduced anaerobic media | Prereduced blood agar formulations | Support anaerobes when incubated without oxygen |
Inoculation. When one specimen is inoculated to several media, inoculate plates before broth, and less selective media before more selective ones, so the richest media receive specimen before the inoculum is depleted. Then streak each plate for isolation. Apply the specimen to one edge and streak through three or four successive quadrants, sterilizing or turning the loop between passes. Each quadrant receives fewer organisms, until single cells are deposited far enough apart to grow into separate colonies. Conventional colony-based identification and susceptibility methods require isolated colonies. Validated direct methods from positive blood-culture broth have their own preparation, purity, and reporting requirements. For specimens in which the organism count affects interpretation, spread a fixed volume over the whole plate with a calibrated loop, commonly 0.001 or 0.01 mL. Multiply the colony count by 1,000 for a 0.001 mL loop and by 100 for a 0.01 mL loop to give colony-forming units (CFU) per milliliter.1
Incubation
Routine bacterial cultures incubate at 35 ± 2 °C. An atmosphere of 5% to 10% CO2 is essential or stimulatory for N. gonorrhoeae, H. influenzae, and S. pneumoniae, so use it whenever feasible.1,4 Incubate selective and differential enteric media such as MacConkey, xylose-lysine-deoxycholate, and Hektoen enteric agar in ambient air. Added CO2 acidifies the medium, which distorts the pH-indicator reactions used for differentiation and can reduce recovery of some gram-negative bacilli.1,14
Anaerobic culture requires rapid transfer to an oxygen-free environment. The routine method is a sealed jar or pouch with a sachet that activates on exposure to air and absorbs oxygen while generating CO2. Current sachet systems require no added water or catalyst. Older generator systems removed residual oxygen by reacting it with hydrogen over a palladium-coated alumina catalyst. High-volume laboratories use an anaerobic chamber, an airtight enclosure filled with an oxygen-free nitrogen-hydrogen-CO2 mixture, entered through a gas-interchange lock, with glove or sleeve ports and an internal incubator. Palladium catalysis with the ambient hydrogen maintains anaerobiosis. Anaerobe recovery is comparable across these systems, which differ in cost, throughput, and convenience.1
Routine plates are examined at 18 to 24 hours and generally incubated for 48 hours. Broths are incubated an additional 24 to 48 hours beyond their plates. Anaerobic plates are first opened at 48 hours, because the colonies grow slowly and early oxygen exposure reduces recovery. Anaerobic plates are incubated for at least 5 days. Organisms that need longer incubation have their own incubation times.1
Reporting cadence
A preliminary report gives a verified finding before planned testing is complete. Its timing follows your laboratory's reporting procedure and the significance of the finding. CLIA does not require a preliminary report at every first examination. Label pending work and preliminary status clearly, so no reader mistakes a preliminary result for a final one. Findings on the laboratory's alert list, such as a verified positive blood-culture Gram stain, trigger the immediate notification pathway without waiting for final identification or susceptibility results.2
The postanalytic reporting lesson explains staged reports, corrections, and documented confirmation that an urgent result reached its recipient. Before you plate a specimen, check the source, the collection time, and the container. Organisms lost or overgrown during collection and transport cannot be recovered at a later step.
Practice
References
- Tille PM. Bailey & Scott's Diagnostic Microbiology. 15th ed. Elsevier; 2021. Back to text
- Laboratory requirements. 42 CFR part 493, §493.1242, §493.1256, §493.1291, §493.1445 (2026). Accessed September 7, 2026. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-493 Back to text
- Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. Published online March 5, 2024. doi:10.1093/cid/ciae104 Back to text
- Papp JR, Schachter J, Gaydos CA, Van Der Pol B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014. MMWR Recomm Rep. 2014;63(RR-2):1-19. Accessed August 28, 2026. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6302a1.htm Back to text
- Lauer BA, Masters HB. Toxic effect of calcium alginate swabs on Neisseria gonorrhoeae. J Clin Microbiol. 1988;26(1):54-56. doi:10.1128/jcm.26.1.54-56.1988 Back to text
- Wadowsky RM, Laus S, Libert T, States SJ, Ehrlich GD. Inhibition of PCR-based assay for Bordetella pertussis by using calcium alginate fiber and aluminum shaft components of a nasopharyngeal swab. J Clin Microbiol. 1994;32(4):1054-1057. doi:10.1128/jcm.32.4.1054-1057.1994 Back to text
- Centers for Disease Control and Prevention. Typhoid and paratyphoid fever. CDC Yellow Book 2026. Accessed August 28, 2026. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/typhoid-and-paratyphoid-fever.html Back to text
- Transportation: hazardous materials regulations. 49 CFR §172.101, §173.27, §173.196, §173.199 (2026). Accessed August 28, 2026. https://www.ecfr.gov/current/title-49/subtitle-B/chapter-I/subchapter-C/part-173 Back to text
- Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 suppl 2):S65-S164. doi:10.1016/j.ajic.2007.10.007 Back to text
- Occupational safety and health standards: bloodborne pathogens; respiratory protection. 29 CFR §1910.1030, §1910.134 (2026). Accessed August 28, 2026. https://www.ecfr.gov/current/title-29/subtitle-B/chapter-XVII/part-1910 Back to text
- Centers for Disease Control and Prevention, National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories. 6th ed. US Department of Health and Human Services; 2020. Accessed August 28, 2026. https://www.cdc.gov/labs/bmbl/index.html Back to text
- Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54(RR-17):1-141. Accessed August 28, 2026. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5417a1.htm Back to text
- Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284. doi:10.1086/425368 Back to text
- Hasan MR, Suleiman M, Ilagan E, et al. Growth of clinically important gram-negative bacteria on MacConkey agar under aerobic versus CO2-enriched environment. J Clin Microbiol. 2019;57(12):e01441-19. doi:10.1128/JCM.01441-19 Back to text